Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × FED × Lymphangioma × Clear all

Phase

Status

Sponsor Class

INDUSTRY 1 FED 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2 Uterine Cervical Dysplasia 1 Ototoxicity 1 Lymphatic Abnormalities 1 Lymphangioma, Cystic 1 Lymphangioma 1 Health Education 1 Colorectal Neoplasms 1 Bowen's Disease 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00010452 2015-03-25

Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations

FDA Office of Orphan Products Development

Phase 2/3 Completed

Lymphangioma, Lymphangioma, Cystic, Lymphatic Abnormalities

Data powered by HemOnc (CC BY 4.0) Colophon ⚡